# US 2004/0079361 A1 · Medicinal aerosols

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0079361 A1
- Document ID: US20040079361A1
- Status: Published application
- Kind: A1
- Application number: 10/467,690
- Filed: 2003-08-08
- Published: 2004-04-29
- Earliest claimed: 2001-01-17
- Inventors: Colin D. Clayton; John S. Scott
- Web page: https://patentgrep.com/patent/US20040079361A1

## CPC

- B65D 83/384: the container body being an aerosol container located in an outer shell or in an external container
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES

## Abstract

A medicinal aerosol product (2) comprising a metal aerosol can (4) equipped with a metering valve (14) and containing a medicinal aerosol formulation, wherein the can is secured within a metal shroud (20) to provide the product with external dimensions substantially equivalent to that of an aerosol can of larger dimensions.

## Claims

### Claim 1

A medicinal aerosol product comprising a metal aerosol can comprising a circular base, cylindrical sidewall extending from the base to an open end to which is attached a metered dose dispensing valve, the aerosol can containing a medicinal aerosol formulation characterised in that the aerosol can is secured within a metal shroud which covers the base of the aerosol can and extends at least partially up the sidewall of the aerosol can to provide the product with external dimensions substantially equivalent to that of an aerosol can of larger dimensions.

### Claim 2 (depends on 1)

A medicinal aerosol product as claimed in claim 1 in which the metal aerosol can comprises a circular base, cylindrical sidewall extending from the base to an open end shoulder region and a neck.

### Claim 3 (depends on 1, 2)

A medicinal aerosol product as claimed in claim 1 or claim 2 in which the shroud is derived from said aerosol can of larger dimensions.

### Claim 4

A medicinal aerosol product as claimed in any preceding claim in which the aerosol can is an interference fit within the shroud.

### Claim 5 (depends on 4)

A medicinal aerosol product as claimed in claim 4 in which the shroud comprises a cylindrical sidewall having at least three dimples forming said interference fit with the external surface of the sidewall of the aerosol can.

### Claim 6 (depends on 4)

A medicinal aerosol product as claimed in claim 4 in which the shroud comprises a cylindrical sidewall having an internal diameter which is an interference fit with the external surface of the sidewall of the aerosol can.

### Claim 7

A medicinal aerosol product as claimed in any preceding claim in which the shroud comprises a sidewall having a circumferential bead acting as a stop to the base of the aerosol can.

### Claim 8 (depends on 1)

A medicinal product as claimed in claim 1 in which the shroud is an aerosol can of larger dimensions comprising a circular base, cylindrical sidewall extending from the base to a shoulder region and a neck; the aerosol can comprises a circumferential lip extending around its open end and over the neck of the shroud and the metered dose dispensing valve is secured to the neck of the shroud and forms a seal with the circumferential lip of the aerosol can.

### Claim 9

A medicinal aerosol product as claimed in any preceding claim in which the aerosol can has a volume of about 5 ml and the external dimensions of the product is equivalent to that of an aerosol can having a volume of about 10 ml or about 15 ml.

### Claim 10

A medicinal aerosol product as claimed in any preceding claim in which the aerosol formulation comprises propellant 134a and/or propellant 227.

### Claim 11

A medicinal aerosol product as claimed in any preceding claim in which the aerosol formulation comprises ethanol.

### Claim 12 (depends on 1)

A medicinal aerosol product as claimed in claim 1 substantially as herein described with reference to the accompanying drawings.

### Claim 13

A method of manufacturing a medicinal aerosol product which comprises the steps of:
preparing a medicinal aerosol formulation for use at a first fill weight in a first aerosol can equipped with a metered dose dispensing valve, the first aerosol can comprising a circular base and a cylindrical side wall extending from the base to an open end to which said valve is attached,
filling said aerosol formulation in a second can which has a volume less than said first can, at a second fill weight which is less than said first fill weight, the second aerosol can comprising a circular base and a cylindrical side extending from the base to an open end to which said metered dose dispensing valve is attached, the aerosol formulation being filled at a second fill weight which is less than said first fill weight such that when dispensed from said second can through said metered-dose dispensing valve the emitted dose will exhibit pharmaceutical characteristics substantially identical to the dose characteristics obtained if said formulation had been filled at said first fill weight in said first can and dispensed the refrom through said metered dose dispensing valve,
wherein said second can is secured within a metal shroud which covers the base of the can and extends at least partially up the sidewall to provide the second with external dimensions substantially identical to said first can.

### Claim 14 (depends on 13)

A method of manufacturing a medicinal method aerosol product as claimed in claim 13 in which the aerosol can is an interference fit within the shroud.

### Claim 15 (depends on 14)

A method of manufacturing a medicinal method aerosol product as claimed in claim 14 in which the shroud comprises a cylindrical sidewall having at least three dimples forming said interference fit with the external surface of the sidewall of the aerosol can.

### Claim 16 (depends on 14)

A method of manufacturing a medicinal method aerosol product as claimed in claim 14 in which the shroud comprises a cylindrical sidewall having an internal diameter which is an interference fit with the external surface of the sidewall of the aerosol can.

### Claim 17 (depends on 13, 14, 15, 16)

A method of manufacturing a medicinal method aerosol product as claimed in any one of claims 13 to 16 in which the shroud comprises a sidewall having a circumferential bead acting as a stop to the base of the aerosol container.

### Claim 18 (depends on 13)

A method of manufacturing a medicinal method aerosol product as claimed in claim 13 in which the shroud is an aerosol can of larger dimensions comprising a circular base, cylindrical sidewall extending from the base to a shoulder region and a neck; the aerosol can comprises a circumferential lip extending around its open end and over the neck of the shroud and the metered dose dispensing valve is secured to the neck of the shroud and forms a seal with the circumferential lip of the aerosol can.

### Claim 19 (depends on 13, 14, 15, 16, 17, 18)

A method of manufacturing a medicinal method aerosol product as claimed in claims 13 to 18 in which said first aerosol can has a volume of about 10 ml or about 15 ml and said second aerosol can has a volume of about 5 ml.

### Claim 20 (depends on 13, 14, 15, 16, 17, 18, 19)

A method of manufacturing a medicinal aerosol product as claimed in any one of claims 13 to 19 in which the aerosol formulation comprises propellant 134a and/or propellant 227.

### Claim 21 (depends on 13, 14, 15, 16, 17, 18, 19, 20)

A method of manufacturing a medicinal aerosol product as claimed in any one of claims 13 to 20 in which the aerosol formulation comprises ethanol.

### Claim 22

A method of manufacturing a medicinal aerosol product substantially as herein described with reference to the accompanying drawings.

### Claim 23

A method of producing a second metered dose inhaler product comprising a medicinal aerosol formulation, aerosol container, valve and actuator that produces fewer doses than a first metered dose inhaler product, where the dose delivery characteristics, formulation, valve size and actuator are the same in the second product as the first product, by using less of the formulation in a smaller aerosol container for the second product, in conjunction with an adapter to permit the smaller aerosol container to fit properly in the actuator.
